| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SID 26681509 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0098 | 0.8 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.012 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.0097 | 0.8 |
| mRNA | embelin | GDSC1000 | pan-cancer | AAC | -0.0088 | 0.8 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |